Published in Clin Transpl on January 01, 2003
Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol (2010) 0.90
Mechanisms involved in antibody- and complement-mediated allograft rejection. Immunol Res (2010) 0.88
ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier. Korean J Hematol (2011) 0.83
Treatment options and strategies for antibody mediated rejection after renal transplantation. Semin Immunol (2011) 0.81
ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier. Indian J Nephrol (2016) 0.78
Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med (2011) 6.72
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med (2004) 3.59
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int (2009) 2.53
Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol (2007) 2.46
Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet (2006) 2.38
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant (2004) 2.22
Inflammatory cells in ischemic acute renal failure. Kidney Int (2004) 2.20
Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg (2010) 2.19
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol (2008) 2.08
Evaluation of potential renal transplant recipients with computed tomography angiography. Arch Surg (2012) 2.07
C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation (2008) 2.04
Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol (2008) 2.03
Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg (2010) 2.01
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
The innate immune response in ischemic acute kidney injury. Clin Immunol (2008) 1.98
Obesity impacts access to kidney transplantation. J Am Soc Nephrol (2007) 1.95
Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl (2013) 1.88
Kidney paired donation and optimizing the use of live donor organs. JAMA (2005) 1.82
Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation (2012) 1.79
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol (2006) 1.77
Is there a role for pancreas transplantation in type 2 diabetes mellitus? Transplantation (2010) 1.74
B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol (2003) 1.73
Morphometric age and surgical risk. J Am Coll Surg (2013) 1.73
Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg (2011) 1.73
ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation (2009) 1.71
A study of renal outcomes in obese living kidney donors. Transplantation (2010) 1.67
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int (2008) 1.67
Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg (2012) 1.65
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg (2006) 1.65
Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant (2003) 1.62
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62
Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J (2006) 1.61
Interactive effects of mechanical ventilation and kidney health on lung function in an in vivo mouse model. Am J Physiol Lung Cell Mol Physiol (2008) 1.59
Prolonged waiting times for liver transplantation in obese patients. Ann Surg (2008) 1.57
Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int (2009) 1.56
Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation (2012) 1.55
Ischemia-reperfusion and immediate T cell responses. Cell Immunol (2007) 1.55
The distant organ effects of acute kidney injury. Kidney Int (2011) 1.55
Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol (2005) 1.54
Kidney-derived stromal cells modulate dendritic and T cell responses. J Am Soc Nephrol (2009) 1.51
Organ crosstalk: the role of the kidney. Curr Opin Crit Care (2009) 1.50
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) (2009) 1.49
Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts. Transplantation (2015) 1.48
There is plenty for everyone: transection of the infracardiac inferior vena cava during organ recovery. Liver Transpl (2012) 1.48
Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg (2011) 1.47
Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg (2010) 1.47
A tale of two provinces: regionalization of pancreatic surgery in Ontario and Quebec. Ann Surg Oncol (2010) 1.47
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46
Cigarette smoking, kidney function, and mortality after live donor kidney transplant. Am J Kidney Dis (2010) 1.45
Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol (2010) 1.44
Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl (2010) 1.38
Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) (2009) 1.38
Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplant (2004) 1.38
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation (2008) 1.35
Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol (2003) 1.33
Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories. BMC Genomics (2008) 1.33
Uremic lung: new insights into a forgotten condition. Kidney Int (2008) 1.31
Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30
Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int (2005) 1.29
The Michigan surgical quality collaborative: will a statewide quality improvement initiative pay for itself? Ann Surg (2007) 1.27
Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2003) 1.27
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol (2006) 1.25
Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant (2005) 1.24
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis (2013) 1.24
Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int (2003) 1.21
Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res (Hoboken) (2012) 1.20
The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One (2011) 1.19
Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest (2005) 1.19
Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int (2008) 1.17
Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis. Am J Physiol Renal Physiol (2009) 1.16
Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant (2005) 1.16
Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation (2014) 1.16
Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation (2004) 1.15
Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation (2006) 1.14
The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. J Neurochem (2006) 1.14